SNSE
Companies
NASDAQ
Sensei Biotherapeutics Inc
Health Care
$7.60
+$7.11 (+1451.02%)
Price Chart
Overview
About SNSE
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing highly selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101, SNS-102, SNS-103, SNS-20.
Market Cap
$16.3M
Volume
124.0M
Avg. Volume
41.7M
P/E Ratio
-0.27491072
Dividend Yield
0.00%
Employees
33.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.84
Moderate Correlation
Volatility
High (1.00)
Relative to market
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, SNSE shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$16.3M
Volume124.0M
P/E Ratio-0.27
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
March 28, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025